GS-5734: a potentially approved drug by FDA against SARS-Cov-2
Zhonglei Wang, Liyan Yang
Abstract
We highlighted the discovery process, preparation techniques, broad-spectrum activities, antiviral mechanism, and future perspectives of GS-5734.
Topics & Concepts
ChemistrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DrugCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakPharmacologyVirologyInternal medicineInfectious disease (medical specialty)DiseaseOutbreakMedicineBiologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesPARP inhibition in cancer therapy